Professor John Wilding: SGLT2 inhibition – a novel strategy to improve type 2 diabetes, cardiovascular & renal outcome


100/100

Production and streaming of this multimedia archive
is made possible by the kind support of

© Copyright At the Limits Limited 2005 – 2016